Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Amifostine
Therapeutic Area : Oncology
Study Phase : Phase II
Recipient : Sun Yat-sen University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 07, 2013
Lead Product(s) : Amifostine
Therapeutic Area : Oncology
Highest Development Status : Phase II
Recipient : Sun Yat-sen University
Deal Size : Inapplicable
Deal Type : Inapplicable